`571-272-7822
`
`
`Paper 17
`Entered: September 11, 2014
`
`
`
`UNITED STATES PATENT AND TRADEMARK OFFICE
`____________
`
`BEFORE THE PATENT TRIAL AND APPEAL BOARD
`____________
`
`MEDTRONIC, INC.,
`Petitioner,
`
`v.
`
`ROBERT BOSCH HEALTHCARE SYSTEMS, INC.,
`Patent Owner.
`____________
`
`Case IPR2014-00488
`Patent 7,769,605 B2
`
`
`Before STEPHEN C. SIU, JUSTIN T. ARBES, and MIRIAM L. QUINN,
`Administrative Patent Judges.
`
`ARBES, Administrative Patent Judge.
`
`DECISION
`Institution of Inter Partes Review
`37 C.F.R. § 42.108
`
`
`
`IPR2014-00488
`Patent 7,769,605 B2
`
`
`Petitioner Medtronic, Inc. filed a Petition (Paper 1, “Pet.”) to institute
`an inter partes review of claims 1–9 of U.S. Patent No. 7,769,605 B2
`(Ex. 1001, “the ’605 patent”) pursuant to 35 U.S.C. §§ 311–19.1 Patent
`Owner Robert Bosch Healthcare Systems, Inc. filed a Preliminary Response
`(Paper 7, “Prelim. Resp.”). We have jurisdiction under 35 U.S.C. § 314.
`For the reasons that follow, we have determined to institute an inter partes
`review.
`
`
`I. BACKGROUND
`The standard for instituting an inter partes review is set forth in
`35 U.S.C. § 314(a):
`THRESHOLD—The Director may not authorize an inter partes
`review to be instituted unless the Director determines that the
`information presented in the petition filed under section 311
`and any response filed under section 313 shows that there is a
`reasonable likelihood that the petitioner would prevail with
`respect to at least 1 of the claims challenged in the petition.
`Petitioner challenges claims 1–9 as unpatentable under 35 U.S.C.
`§ 103(a). Pet. 14–60. We institute an inter partes review as to claims 1–9
`on certain grounds of unpatentability as discussed below.
`
`
`A. The ’605 Patent
`The ’605 patent describes a system for “monitoring a group of
`patients having a chronic disease or ongoing health condition” by
`monitoring certain parameters of the condition, such as blood glucose level
`
`1 Cardiocom, LLC (“Cardiocom”), a wholly-owned subsidiary of Petitioner,
`previously filed a petition seeking inter partes review of the ’605 patent in
`Case IPR2013-00439. The petition was denied on January 16, 2014.
`Ex. 1010 (“-439 Dec.”).
`
`
`
`2
`
`
`
`IPR2014-00488
`Patent 7,769,605 B2
`
`for diabetes and blood pressure for hypertension. Ex. 1001, Abstract; col. 1,
`ll. 25–37. According to the ’605 patent, in prior art outpatient treatment
`programs, a clinician often learned about a patient’s status through “patient
`initiated events,” such as a visit to the emergency room. Id. at col. 1,
`ll. 48–67. As a result, medical needs of unmotivated patients could be
`overlooked. Id. In addition, prior art computer systems displayed medical
`data only on an “individual patient basis,” making it difficult to determine
`“which patients are having the greatest difficulty in controlling their health
`condition so that the clinician may focus attention on these patients.” Id.
`at col. 2, ll. 1–8. Consequently, according to the ’605 patent, a need existed
`in the art to “view medical data for an entire group of patients
`simultaneously.” Id. at col. 2, ll. 6–8.
`Figure 1 of the ’605 patent is reproduced below.
`
`
`
`3
`
`
`
`
`
`IPR2014-00488
`Patent 7,769,605 B2
`
`Figure 1 above depicts healthcare clinic 10 in communication with patient
`sites 36 and 46 via communication network 34. Id. at col. 4, ll. 39–65.
`Patient site 36 includes monitoring device 42 for measuring periodically a
`particular health parameter of the patient, such as the patient’s blood glucose
`level, and transmitting the measurements to healthcare clinic 10. Id. at col.
`5, ll. 11–23. Patient site 36 also includes patient unit 38 (e.g., a personal
`computer) with message display 40 for displaying messages received from
`the clinic (e.g., emails). Id. at col. 4, l. 66–col. 5, l. 10.
`Healthcare clinic 10 comprises clinic server 12 and clinician
`workstation 22. Ex. 1001, col. 4, ll. 39–65. Clinic server 12 includes master
`patient database 18 for storing patient data and overview application 20 for
`“performing various calculations using the patient data” and “generating a
`group overview chart with the patient data.” Id. at col. 4, ll. 49–54.
`Overview application 20 calculates a “control value” for a patient indicating
`the patient’s “control over the health condition” (e.g., the mean value of a
`parameter over a given period of time). Id. at col. 6, ll. 16–28. The control
`values for a group of patients then are displayed in group overview chart 26
`on clinician workstation 22. Id. at col. 4, ll. 58–62.
`
`
`
`4
`
`
`
`IPR2014-00488
`Patent 7,769,605 B2
`
`
`Figure 3 of the ’605 patent depicts an exemplary group overview chart
`for a group of ten diabetes patients, and is reproduced below.
`
`
`As shown in Figure 3 above, group overview chart 26 has “ten data points,
`each data point representing one corresponding patient and indicating the
`control value calculated for the patient and the time period elapsed since the
`patient’s most recent collection date,” with each data point represented by an
`icon (e.g., icon 66). Ex. 1001, col. 7, ll. 20–25. According to the ’605
`patent, viewing such a chart allows a clinician to determine which patients
`are having difficulty with their condition and require greater attention. Id. at
`col. 8, ll. 34–43.
`
`
`B. Illustrative Claim
`Claim 1 of the ’605 patent recites:
`1. A system for monitoring a plurality of patients
`regarding a health condition, comprising:
`a reception unit for receiving a corresponding set of
`measurements regarding said health condition from each patient
`included in the plurality of patients;
`
`
`
`5
`
`
`
`IPR2014-00488
`Patent 7,769,605 B2
`
`
`a processing unit in communication with said reception
`unit for processing said corresponding set of measurements and
`identifying at least one patient included in the plurality of
`patients based upon said processing of said corresponding set of
`measurements;
`a database, the database being in communication with
`said processing unit, the database being configured for storing
`medical health history information for each patient included in
`the plurality of patients, wherein processing of said
`corresponding set of measurements by the processing unit
`includes evaluating said corresponding set of measurements
`against said stored medical health history information;
`a transfer unit in communication with said processing
`unit, wherein said transfer unit communicates with said at least
`one identified patient, said transfer unit being configured for
`transmitting a message for communicating with said at least one
`identified patient, the message being based upon said medical
`health history
`information and said processing of said
`corresponding set of measurements, the message being one of:
`a telephone message and an electronic mail message; and
`a display unit in communication with said processing
`unit, the display unit being configured for displaying a group
`overview chart, said group overview chart being generated by
`the processing unit based upon said processing and being
`provided to said display unit, said group overview chart
`including a plurality of data points, wherein each of the data
`points represents one corresponding patient included in the
`plurality of patients and indicates at least one control value for
`the one corresponding patient,
`the control value being
`indicative of the one corresponding patient’s control over said
`health condition, the control value being based upon said
`corresponding set of measurements, each data point including
`an icon.
`
`
`
`6
`
`
`
`
`
`IPR2014-00488
`Patent 7,769,605 B2
`
`
`C. The Prior Art
`Petitioner relies on the following prior art:
`1. U.S. Patent No. 5,331,549, issued July 19, 1994
`(“Crawford”) (Ex. 1006);
`2. U.S. Patent No. 5,471,382, issued November 28, 1995
`(“Tallman”) (Ex. 1008);
`3. U.S. Patent No. 5,827,180, issued October 27, 1998,
`continuation of an application
`filed August 24, 1995
`(“Goodman”) (Ex. 1002);
`4. U.S. Patent No. 5,942,986, issued August 24, 1999,
`filed August 9, 1995 (“Shabot”) (Ex. 1003);
`5. G.F. Groner et al., An Introduction to the CLINFO
`Prototype Data Management and Analysis System, National
`Institutes of Health, R-1541-NIH, 1–57 (Dec. 1977) (“Groner”)
`(Ex. 1007);
`6. M. Michael Shabot & Reed M. Gardner, ed., DECISION
`SUPPORT SYSTEMS IN CRITICAL CARE (1994) (“Shabot Book”)
`(Ex. 1004);2 and
`7. E. Chris Vincent et al., The Effects of a
`Computer-Assisted Reminder System on Patient Compliance
`With Recommended Health Maintenance Procedures, AMIA,
`Inc., 656–60 (1995) (“Vincent”) (Ex. 1005).
`
`D. The Asserted Grounds
`Petitioner challenges claims 1–9 of the ’605 patent under 35 U.S.C.
`§ 103(a) on the following grounds:
`References
`
`Claim(s)
`Challenged
`1 and 3–9
`
`Goodman and Shabot
`
`
`2 As explained herein, Petitioner argues that the Shabot Book is incorporated
`by reference in Shabot. See infra Section II.C.3.
`
`
`
`7
`
`
`
`IPR2014-00488
`Patent 7,769,605 B2
`
`
`References
`
`Goodman, Shabot, and Vincent
`
`Goodman, Shabot, and Crawford
`
`Claim(s)
`Challenged
`2
`
`1 and 3–9
`
`Goodman, Shabot, Crawford, and Vincent
`
`2
`
`Goodman, Shabot, and Groner
`
`1 and 3–9
`
`Goodman, Shabot, Groner, and Vincent
`
`2
`
`Goodman, Shabot, Crawford, and Tallman
`
`1 and 3–9
`
`Goodman, Shabot, Crawford, Tallman, and
`Vincent
`
`2
`
`
`
`E. Claim Interpretation
`Consistent with the statute and legislative history of the Leahy-Smith
`America Invents Act, Pub. L. No. 112-29, 125 Stat. 284 (2011) (“AIA”), the
`Board interprets claims using the “broadest reasonable construction in light
`of the specification of the patent in which [they] appear[].” 37 C.F.R.
`§ 42.100(b); see also Office Patent Trial Practice Guide, 77 Fed. Reg.
`48,756, 48,766 (Aug. 14, 2012) (“Trial Practice Guide”). In our decision
`denying institution in Case IPR2013-00439, we interpreted the term “chart”
`in claim 1 of the ’605 patent to mean “information arranged in the form of
`one or more tables, graphs, or diagrams,” and interpreted the term “icon” in
`claim 1 to mean “a graphical representation of an underlying function or
`data.” -439 Dec. 8–12. Petitioner argues that the terms should be
`interpreted in the same manner in this proceeding, and Patent Owner applies
`our previous interpretations in its Preliminary Response. See Pet. 7; Prelim.
`
`
`
`8
`
`
`
`IPR2014-00488
`Patent 7,769,605 B2
`
`Resp. 12. We incorporate our previous analysis for purposes of this decision
`and determine that the broadest reasonable interpretations of the terms
`“chart” and “icon” are the same interpretations that were articulated in the
`decision denying institution in Case IPR2013-00439. See -439 Dec. 8–12.
`
`II. DISCUSSION
`We turn now to Petitioner’s asserted grounds of unpatentability and
`Patent Owner’s arguments in its Preliminary Response to determine whether
`Petitioner has met the threshold standard of 35 U.S.C. § 314(a).
`
`A. Section 312(a)(2)
`As an initial matter, Patent Owner argues that the Petition should be
`denied for failure to “identif[y] all real parties in interest” under 35 U.S.C.
`§ 312(a)(2). Prelim. Resp. 7–9. Petitioner states in its Petition that it is the
`sole real party-in-interest. Pet. 1. Patent Owner argues that Cardiocom also
`is a real party-in-interest, relying on the following facts: (1) Cardiocom
`previously filed a petition in Case IPR2013-00439 seeking inter partes
`review of the ’605 patent; (2) Cardiocom and Petitioner both are listed as
`real parties-in-interest in Case IPR2013-00439;3 (3) Cardiocom and
`Petitioner both are defendants in the related district court case where the
`’605 patent is being asserted; (4) Petitioner has the same counsel and
`declarant, Robert T. Stone, Ph.D., in this proceeding as Cardiocom had in
`Case IPR2013-00439; and (5) Petitioner relies on many of the same prior art
`
`
`3 Cardiocom listed itself as the sole real party-in-interest when it filed its
`petition, but later added Petitioner after Petitioner acquired Cardiocom.
`See IPR2013-00439, Paper 3 at 1, Paper 25.
`
`
`
`9
`
`
`
`IPR2014-00488
`Patent 7,769,605 B2
`
`references as Cardiocom did in Case IPR2013-00439. Prelim. Resp. 7–9.
`Based on these facts, Patent Owner contends that Cardiocom “desires
`review” of the ’605 patent and was “involved” in the filing of the Petition.
`Id. at 7–8. Patent Owner also argues that even if Petitioner was permitted to
`correct its Petition to identify Cardiocom, doing so would be futile because
`Cardiocom was served with a complaint alleging infringement of the ’605
`patent more than one year ago under 35 U.S.C. § 315(b). Id. at 8–9.
`Whether a non-party is a “real party-in-interest” for purposes of an
`inter partes review proceeding is a “highly fact-dependent question” that
`takes into account how courts generally have used the term to “describe
`relationships and considerations sufficient to justify applying conventional
`principles of estoppel and preclusion.” Trial Practice Guide, 77 Fed. Reg. at
`48,759. In general, a “real party-in-interest” is “the party that desires review
`of the patent,” and “may be the petitioner itself, and/or it may be the party or
`parties at whose behest the petition has been filed.” Id. Depending on the
`circumstances, various factors may be considered, including whether the
`non-party exercises, or could exercise, control over the petitioner’s
`participation in the proceeding, and whether the non-party is funding or
`directing the proceeding. Id. at 48,759–60.
`Patent Owner has not provided a sufficient factual basis upon which
`to conclude, based on the current record, that Cardiocom is a real
`party-in-interest in this proceeding. Petitioner is the party seeking inter
`partes review, and represents that it is the sole real party-in-interest. See
`Pet. 1. The fact that Cardiocom previously filed a petition in another
`proceeding, without more, does not establish anything about which entity, or
`entities, are responsible for controlling, funding, or directing Petitioner’s
`
`
`
`10
`
`
`
`IPR2014-00488
`Patent 7,769,605 B2
`
`activities in this proceeding. Nor does the fact that both Cardiocom and
`Petitioner are defendants in the district court case—also a different
`proceeding—indicate, without more, that both entities must be involved in
`this proceeding. We also note that Cardiocom is a wholly-owned subsidiary
`of Petitioner, indicating that Petitioner has the ability to exercise some
`measure of control over its subsidiary, and not necessarily the reverse.
`Patent Owner has not pointed to sufficient facts to show, at this stage of the
`proceeding, that Petitioner failed to name all real parties-in-interest, and we
`do not deny the Petition on that basis.
`
`
`B. Section 325(d)
`In Case IPR2013-00439, Cardiocom asserted similar grounds to those
`asserted by Petitioner in this proceeding, relying on five of the same prior art
`references: Goodman, Crawford, Groner, Tallman, and Vincent. Compare
`IPR2013-00439, Paper 3 at 20–56 with Pet. 14–60. We determined that
`Cardiocom had not shown sufficiently that either Crawford or Goodman
`teaches a processing unit for “evaluating said corresponding set of
`measurements against said stored medical health history information,”
`as recited in claim 1. -439 Dec. 13–19. Petitioner now relies on a new
`reference, Shabot, which was not considered during prosecution of the ’605
`patent, as allegedly teaching the “evaluating” limitation. Pet. 47–48.
`Petitioner also relies on Goodman as teaching the majority of limitations of
`the claims, unlike in Case IPR2013-00439 where Cardiocom relied primarily
`on Crawford. Compare IPR2013-00439, Paper 3 at 20–35 with Pet. 25–41.
`Patent Owner argues that the Petition should be denied under
`35 U.S.C. § 325(d) because it relies on five of the same prior art references
`
`
`
`11
`
`
`
`IPR2014-00488
`Patent 7,769,605 B2
`
`as the petition in Case IPR2013-00439 and Shabot is “cumulative” to the
`prior art and arguments in the earlier case. Prelim. Resp. 4–5. Patent Owner
`also contends that Petitioner and Cardiocom have filed numerous other
`petitions for inter partes review and requests for ex parte reexamination of
`patents asserted in the district court case, causing unnecessary delay and
`expense for Patent Owner. Id. at 5–6 (citing, for example, Reexamination
`Control No. 90/013,167, a pending ex parte reexamination of the ’605
`patent).
`In determining whether to institute an inter partes review, “the
`Director may take into account whether, and reject the petition or request
`because, the same or substantially the same prior art or arguments previously
`were presented to the Office.” 35 U.S.C. § 325(d). The statutory language
`gives the Director the authority not to institute review on the basis that the
`same or substantially the same prior art or arguments were presented
`previously to the Office, but does not require that result. Shabot, and the
`specific combinations of Shabot and other prior art asserted by Petitioner in
`this proceeding, were not considered during prosecution of the ’605 patent
`or during Case IPR2013-00439. Although we are mindful of the burden on
`Patent Owner and the Office in analyzing the other, previously considered
`five references, we conclude that Petitioner’s arguments regarding Shabot
`and the “evaluating” limitation are persuasive, as explained herein, and thus,
`we do not exercise our discretion to deny the Petition under 35 U.S.C.
`§ 325(d).
`
`
`
`
`12
`
`
`
`IPR2014-00488
`Patent 7,769,605 B2
`
`
`C. Asserted Ground Based on Goodman and Shabot
`Petitioner contends that claims 1 and 3–9 are unpatentable over
`Goodman and Shabot under 35 U.S.C. § 103(a), and relies on the declaration
`of Dr. Stone (Ex. 1018) in support. Pet. 25–32, 41–60. For the reasons
`explained below, we are not persuaded that Petitioner has established a
`reasonable likelihood of prevailing on the asserted ground.
`
`
`1. Goodman
`Goodman discloses a system for monitoring the health of a patient in
`which a third party host computer is in communication with a health care
`provider’s computer and a patient’s computer. Ex. 1002, Abstract; col. 2,
`ll. 44–51; Fig. 1. In one embodiment, the host computer receives a treatment
`plan for a patient from the health care provider and generates an algorithm
`based on the treatment plan. Id. at col. 2, ll. 54–57. The algorithm is
`programmed into a message device in possession of the patient. Id. at col. 2,
`ll. 49–58. The message device prompts the patient to measure and enter
`physiological data as dictated by the treatment plan. Id. at col. 2, ll. 58–61.
`The host computer receives the data and “functions as a central station for
`collecting, analyzing, and routing data” received from patients. Id. at col. 2,
`l. 51–col. 3, l. 2.
`
`
`2. Shabot
`Shabot discloses a “critical event notification system [that]
`continuously monitors patient statistics and lab data to detect critical events,
`and automatically pages a responsible physician.” Ex. 1003, Abstract. The
`system receives real-time data regarding patients, stores the data in “patient
`
`
`
`13
`
`
`
`IPR2014-00488
`Patent 7,769,605 B2
`
`chart databases” and “databases corresponding to patient history,”
`periodically analyzes the data to determine whether a “critical event” or
`“exception condition” has occurred, and, if so, sends an alphanumeric
`message with information about the event to the responsible physician. Id.,
`Abstract; col. 2, ll. 28–65; col. 10, l. 46–col. 11, l. 23.
`
`
`3. Analysis
`Claim 1 recites a display unit configured to display a “group overview
`chart” with a plurality of data points, where each data point (1) represents a
`patient, (2) indicates a “control value” for the patient indicative of the
`patient’s control over a health condition, and (3) includes an “icon.”
`Petitioner relies on Shabot as allegedly teaching these limitations, citing
`general statements in Shabot that the disclosed system monitors multiple
`patients, analyzes the received data, and displays “lab results, charts, or other
`data” on a workstation display screen. Pet. 18–19, 51–52 (emphasis
`omitted). Petitioner, however, does not explain specifically how these
`general statements teach a chart having data points for particular patients or
`data points indicating control values. Thus, we are not persuaded that the
`disclosure of Shabot itself teaches a “group overview chart” as recited in
`claim 1.
`Petitioner also relies on portions of the Shabot Book describing a
`display screen in the “APACHE III” medical computer system, and asserts
`that they are incorporated by reference in Shabot. Id. at 19–20, 52–54
`(citing Ex. 1004). The Shabot Book states that the APACHE III system
`displays a screen having intensive care unit (“ICU”) patients each
`represented by a “stylized bed symbol,” and showing each “patient’s risk of
`
`
`
`14
`
`
`
`IPR2014-00488
`Patent 7,769,605 B2
`
`both ICU and hospital death through the coordinated use of color-coded
`information.” Ex. 1004 at 250–51. Petitioner argues that the Shabot Book is
`incorporated by reference in the following passage from Shabot:
`Those desiring additional detail as to the interface between
`these computer systems 71 or 73 and the clinical information
`system 61, and how new data from these computer systems is
`processed, are referred to the following references: . . . Decision
`Support Systems In Critical Care, Ed. M. Michael Shabot and
`Reed Gardner (Springer-Verlag 1994). These references are
`hereby incorporated by reference into this disclosure, as though
`fully set forth herein.
`Ex. 1003, col. 12, ll. 7–22; see Pet. 19–20. Patent Owner responds that the
`portions of the Shabot Book relied upon by Petitioner are not incorporated
`by reference in Shabot. Prelim. Resp. 35–38. We agree with Patent Owner.
`“To incorporate material by reference, the host document must
`identify with detailed particularity what specific material it incorporates and
`clearly indicate where that material is found in the various documents.”
`Advanced Display Sys., Inc. v. Kent State Univ., 212 F.3d 1272, 1282–83
`(Fed. Cir. 2000). Whether a patent describes material to be incorporated by
`reference with sufficient particularity is assessed from the perspective of a
`person of ordinary skill in the art. Id. at 1283.
`The Shabot Book is a 420-page publication comprising 25 different
`chapters on different subjects. See Ex. 1004 at xi. Shabot does not identify
`clearly any particular portion or material from the Shabot Book as being
`incorporated by reference, instead referring only to the publication as a
`whole. Also, in introducing the Shabot Book, Shabot explicitly refers the
`reader to the reference for “additional detail” regarding the “interface”
`between computer systems 71/73 and clinical information system 61 and
`“how new data from these computer systems is processed.” Ex. 1003, col.
`
`
`
`15
`
`
`
`IPR2014-00488
`Patent 7,769,605 B2
`
`12, ll. 7–22. To the extent this statement could be considered a reference to
`specific material in the Shabot Book, the Shabot Book’s description of the
`APACHE III system display screen does not pertain to an interface between
`computer systems or how data from different computer systems is processed.
`Thus, we are not persuaded that the cited portions of the Shabot Book are
`incorporated by reference in Shabot. Further, even if the cited portions of
`the Shabot Book pertaining to the APACHE III system were incorporated by
`reference in Shabot, Petitioner has not shown sufficiently that a person of
`ordinary skill in the art would have had reason to combine those specific
`disclosures with the other teachings of Shabot and Goodman. See Prelim.
`Resp. 37. Thus, Petitioner has not established a reasonable likelihood of
`prevailing on its assertion that independent claim 1, as well as dependent
`claims 3–9, are unpatentable over Goodman and Shabot under 35 U.S.C.
`§ 103(a).
`
`
`D. Asserted Ground Based on Goodman, Shabot, and Vincent
`Petitioner contends that claim 2 is unpatentable over Goodman,
`Shabot, and Vincent under 35 U.S.C. § 103(a). Pet. 40–41, 56–57. As
`explained above, Petitioner has not shown that Goodman and Shabot teach
`the “group overview chart” limitations of claim 1. Petitioner does not rely
`on Vincent for the limitations and, therefore, has not established a
`reasonable likelihood of prevailing as to claim 2 for the same reasons.
`
`E. Asserted Ground Based on Goodman, Shabot, and Crawford
`Petitioner contends that claims 1 and 3–9 are unpatentable over
`Goodman, Shabot, and Crawford under 35 U.S.C. § 103(a), again relying on
`
`
`
`16
`
`
`
`IPR2014-00488
`Patent 7,769,605 B2
`
`the testimony of Dr. Stone in support. Pet. 33–36, 41–60. We are persuaded
`that Petitioner has established a reasonable likelihood of prevailing on the
`asserted ground for the reasons explained below.
`
`
`1. Crawford
`Crawford discloses a “medical monitoring system in which a plurality
`of vital signs monitors for a plurality of patients provide data on a continuing
`basis to a central server.” Ex. 1006, Abstract. The system provides an
`overview display (e.g., a computer touchscreen) showing, for example, a
`hospital floor plan with room icons. Id. at col. 5, ll. 19–23; col. 6, ll. 34–38.
`Alarms and warnings are displayed whenever a patient’s monitored vital
`signs fall outside a range pre-selected by the health care provider. Id. at col.
`5, ll. 23–37; col. 8, ll. 22–44. Figure 3 of Crawford is reproduced below.
`
`
`
`
`
`17
`
`
`
`IPR2014-00488
`Patent 7,769,605 B2
`
`Figure 3 above depicts Room 221with a critical emergency and Rooms 208
`and 228 with warnings. Id. at col. 5, ll. 23–58. A user can touch the screen
`on a particular room to call up information for the particular patient. Id. at
`col. 6, ll. 34–38. The system also can display past vital sign measurements
`for a patient. Id. at col. 2, ll. 34–37; col. 8, ll. 52–62; Fig. 7.
`
`
`2. Analysis
`Petitioner contends that Goodman, Shabot, and Crawford teach all of
`the limitations of claim 1. Pet. 33–36, 41–56. For example, Petitioner cites
`Shabot for the “evaluating” limitation and Crawford’s overview display for
`the “group overview chart” limitations. Id. at 47–48, 54–56. Upon review
`of Petitioner’s analysis and supporting declaration, we are persuaded that
`Petitioner has shown a reasonable likelihood of prevailing on its asserted
`ground of unpatentability of claim 1 based on the combination of Goodman,
`Shabot, and Crawford.
`Patent Owner makes five arguments. First, Patent Owner argues that
`Shabot does not teach a “processing unit” for “processing said
`corresponding set of measurements,” wherein the processing includes
`“evaluating said corresponding set of measurements against said stored
`medical health history information,” as recited in claim 1. Prelim. Resp.
`27–30. Patent Owner contends that the limit values in Shabot are “default
`values set by a lab technician,” not based on any “medical health history
`information” or set by a “processing unit.” Id. Patent Owner’s arguments
`are not persuasive. The server workstation in Shabot accesses real-time
`patient data and periodically updated hospital databases, including
`“databases corresponding to patient history.” Ex. 1003, Abstract; Figs. 2–3;
`
`
`
`18
`
`
`
`IPR2014-00488
`Patent 7,769,605 B2
`
`col. 8, ll. 14–22; col. 11, l. 53–col. 12, l. 37. The server workstation can
`detect a singular critical event, such as “a drop in a patient’s calcium level
`(as determined from periodic analysis of the patient’s blood) below a
`predetermined critical level.” Id. at col. 2, l. 66–col. 3, l. 4; col. 6, ll. 29–36.
`Importantly, though, it also can detect an exception condition based on
`patient data collected over time. For instance, an exception condition may
`be when “the patient . . . required levels of oxygen ventilation of greater than
`60% oxygen composition for over four hours duration,” determined by
`reviewing “several, time-spanned data entries” for the patient. Id. at col. 10,
`ll. 51–59; col. 6, ll. 36–47 (“[t]his type of analysis cannot be performed upon
`instantaneous measurements”). Based on the current record, we are
`persuaded that the latter type of processing constitutes evaluating a set of
`measurements against stored medical health history information, as required
`by claim 1. See Pet. 47–48; Ex. 1018 ¶¶ 44–47.
`Second, Patent Owner argues that Goodman and Shabot do not teach a
`“transfer unit” that transmits a telephone message or electronic mail message
`to a patient, as recited in claim 1. Prelim. Resp. 30–32. Goodman discloses
`host computer 30 in communication with wireless carrier 60, which
`“‘telephones’ the patient’s pager 61” and delivers a message to the patient,
`such as a reminder for the patient to take his or her medication. Ex. 1002,
`col. 5, l. 64–col. 6, l. 7. Goodman further discloses the transmission of
`information to a patient “via telephone, facsimile transmission, electronic
`mail, or other communication means.” Id. at col. 7, l. 66–col. 8, l. 5.
`Dr. Stone testifies that “the pager and modem messages specifically
`disclosed by Goodman for transmitting health-related messages to patients
`[are] examples,” and “[o]ne of ordinary skill would understand that the other
`
`
`
`19
`
`
`
`IPR2014-00488
`Patent 7,769,605 B2
`
`means of communication disclosed by Goodman, telephone, and electronic
`mail, were also viable methods to transfer messages to patients.” Ex. 1018
`¶ 52. Petitioner has made a sufficient showing regarding the “transfer unit”
`limitations of claim 1. See Pet. 29, 48–49; Ex. 1018 ¶¶ 49, 51–52.
`Third, Patent Owner contends that Crawford does not teach a “group
`overview chart” with separate “data points” and “icons,” as recited in claim
`1. Prelim. Resp. 38–39. As explained above, we interpret “chart” to mean
`“information arranged in the form of one or more tables, graphs, or
`diagrams,” and interpret “icon” to mean “a graphical representation of an
`underlying function or data.” See supra Section I.E. Based on the current
`record, Petitioner has shown sufficiently that Crawford’s overview display is
`a chart having data points, each representing one patient and indicating a
`value for the patient (e.g., a warning situation) based on measurements for
`the patient, with each data point having an icon (image of a room), as recited
`in claim 1. See Pet. 54–56.
`Fourth, Patent Owner argues that a person of ordinary skill in the art
`would not have had reason to combine the teachings of Goodman, Shabot,
`and Crawford. Prelim. Resp. 42–45. In its Petition, Petitioner contends that
`Goodman and Shabot both describe “remote monitoring systems that
`monitor patients over time (e.g., based on health history),” and a person of
`ordinary skill in the art would have been motivated to incorporate Shabot’s
`evaluation against medical health history information into Goodman’s
`monitoring system “to provide periodic reports to a primary provider,
`allowing that provider to determine if the patient is following a particular
`treatment.” Pet. 27–28; see Ex. 1018 ¶¶ 31–34, 40–41. Further, according
`to Petitioner, a skilled artisan would have been motivated to expand
`
`
`
`20
`
`
`
`IPR2014-00488
`Patent 7,769,605 B2
`
`Goodman’s monitoring system to include alerts based on data collected over
`time, as taught by Shabot, to improve “automation and efficiency in
`detecting health conditions of concern” and help health care professionals
`detect “critical situation[s].” Pet. 31; see Ex. 1018 ¶¶ 45, 47–48. As to
`Crawford, Petitioner contends that the reference is directed to “monitoring of
`patient populations,” just like Goodman and Shabot, and a person of
`ordinary skill in the art would have been motivated to incorporate
`Crawford’s overview display into the other monitoring systems to “enhance
`the remote monitoring capabilities available” by using a display where
`“multiple patients can be quickly monitored at once.” Pet. 33–36; see
`Ex. 1018 ¶ 90. Dr. Stone testifies regarding these and other reasons why a
`person of ordinary skill in the art would have had reason to combine the
`teachings of the references to arrive at the claimed system. See, e.g.,
`Ex. 1018 ¶¶ 31–92.
`Patent Owner argues that the system of Goodman is so different from
`the systems of Shabot and Crawford that a skilled artisan would not have
`thought to combine them. Prelim. Resp. 42–45.